Drug Profile


Alternative Names: Anseculin hydrochloride; Ensaculin hydrochloride; KA 672 hydrochloride

Latest Information Update: 24 Jan 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Unknown
  • Developer Dr. Willmar Schwabe Group
  • Class Coumarins; Neuroprotectants; Nootropics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Alzheimer's disease

Most Recent Events

  • 24 Jan 2003 Discontinued - Phase-III for Alzheimer's disease in Germany (PO)
  • 05 Feb 2001 KA 672 hydrochloride is now called ensaculin (INN)
  • 05 Feb 2001 Phase-III clinical trials for Alzheimer's disease in Germany (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top